Scientists investigate gut Microbiome's role in lung cancer therapy
NCT ID NCT06221800
First seen Feb 05, 2026 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This pilot study is collecting stool and saliva samples from 82 people with advanced non-small cell lung cancer to see if the diversity of their gut microbiome is linked to how well their treatment works and what side effects they experience. The goal is to better understand the relationship between gut bacteria and cancer therapy outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Chao Family Comprehensive Cancer Center University of California, Irvine
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could reveal how gut bacteria influence lung cancer treatment outcomes, potentially guiding future personalized therapies.
What could go wrong
This is a small pilot study (82 participants) focused on observation, not treatment. It may not produce clear or generalizable results.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.